Skip to main content
. 2014 Dec 1;1:17. doi: 10.1186/s40673-014-0017-4

Figure 1.

Figure 1

The MR spectroscopy of the patients at the initial (upper) and follow-up (lower) assessments. (A) healthy controls, (B) SCA2, (C) SCA3, (D) SCA6 and (E) MSA-C.